Corporate calendar for Aptevo Therapeutics Inc. (APVO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | $159M | |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | ||
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-12-30 | 1:18 |
| 2025-05-27 | 1:20 |
| 2024-12-04 | 1:37 |
| 2024-03-06 | 1:44 |
| 2020-03-27 | 1:14 |
Price
| Price | $1.72 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ABP · BCDA · CERO · EPIX · ERNA · HCWB · INAB
Explore sector: Healthcare · Biotechnology
More sections of APVO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks